Influenza Vaccine Clinical Trial
Official title:
A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Trivalent Inactivated Influenza Vaccine in Adult Solid Organ Transplant Recipients
Influenza virus is an important cause of morbidity in the transplant population and can lead to viral and bacterial pneumonia and contribute to the development of rejection. Although the annual influenza vaccine is recommended for transplant patients, studies have shown that a single intramuscular dose has poor immunogenicity. There are no studies that define the effect of intradermal doses in this population. We plan to study the immunogenicity of two different administration routes of the influenza vaccine in 200 solid organ transplant patients during the 2010-2011 season. Patients will be randomized to receive influenza vaccine either intradermally or intramuscularly. We hypothesize that the patients who receive the intradermal influenza vaccine will significantly reach a higher response to the vaccine. This study advances research on the prevention of serious viral infections in transplant recipients. Results from this study have the potential to directly improve patient care. If the use of the intradermal influenza vaccine is successful, this strategy may lead to a significant reduction in burden of disease, hospitalizations, and long-term morbidity.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03285997 -
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
|
Phase 3 | |
| Recruiting |
NCT05996549 -
Cost-effectiveness of the Influenza Vaccination
|
Phase 4 | |
| Completed |
NCT04546854 -
Influenza 2020/2021
|
N/A | |
| Completed |
NCT05157425 -
Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination
|
N/A | |
| Completed |
NCT01687517 -
Efficacy and Safety of Influenza Vaccine During Sarcoidosis
|
Phase 3 | |
| Completed |
NCT00760175 -
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients
|
N/A | |
| Completed |
NCT00542776 -
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
|
N/A | |
| Completed |
NCT06304038 -
Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome
|
||
| Recruiting |
NCT04086628 -
Influenza Vaccine in Children With Asthma
|
||
| Completed |
NCT02960815 -
Imiquimod and Influenza Vaccine for Immunocompromised Patients
|
Phase 2 | |
| Completed |
NCT00828555 -
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
|
N/A | |
| Completed |
NCT04230343 -
Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour
|
N/A | |
| Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A | |
| Completed |
NCT02153671 -
Immunogenicity of H5N1 Vaccine Following H5N2
|
Phase 2 | |
| Completed |
NCT00461981 -
A Phase 2 Study to Evaluate Immune Responses of FluMist®
|
Phase 2 | |
| Recruiting |
NCT05070494 -
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
|
Phase 4 | |
| Completed |
NCT04785794 -
Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
|
Phase 1 | |
| Completed |
NCT05163847 -
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults
|
Phase 1 | |
| Not yet recruiting |
NCT04355806 -
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
|
||
| Completed |
NCT01368796 -
Comparison of 4 Influenza Vaccines in Seniors
|
Phase 4 |